Key facts
- This page summarizes William A. Wexler's Form 4 filing for Comera Life Sciences Holdings, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 17 Nov 2023, 16:13.
William A. Wexler - 15 Nov 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 15 Nov 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Nov 2023, 16:13:17 UTC
- Prior SEC filing
- 14 Nov 2023
- Next SEC filing
- 10 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ryan M. Rourke Reed, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William A. Wexler filed Form 4 for Comera Life Sciences Holdings, Inc. on 17 Nov 2023.
Change
- Previous filing in this sequence was filed on 14 Nov 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CMRA
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +3,113
- Change %
- +18%
- Price
- $0.000000
- Shares after
- 20,811
- Date
- 15 Nov 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Reflects a pro rata distribution to the reporting person by OTR Acquisition Sponsor LLC of the issuer's common stock on November 15, 2023.